Umbilical Cord Mesenchymal Stem Cell Therapy (Shandong Baihong Stem Cell Biotech)

脐带间充质干细胞疗法(山东佰鸿干细胞)

Report date: 2026/05/28 20:00:21

Base Information

Drug NameUmbilical Cord Mesenchymal Stem Cell Therapy (Shandong Baihong Stem Cell Biotech)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShandong Baihong Stem Cell Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Baihong Stem Cell Biotechnology Co LtdShaanxi Baihong Stem Cell Biotechnology Co LtdGuangdong Baihong Stem Cell Regenerative Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A